#GS3 #Health #Covid19
The Drugs Controller General of India (DCGI) on September 19, 2020, approved the commercial launch of ‘Feluda’, the TATA CRISPER (Clustered Regulatory Interspaced Short Palindromic Repeats) COVID-19 test. The news was shared by the Council of Scientific and Industrial Research (CSIR).
- According to the Indian Council of Medical Research (ICMR) guidelines, the test has met the high-quality benchmarks with 96% sensitivity and 98% specificity for detecting the Coronavirus.
- The TATA CRISPER test will be the world’s first diagnostic test to deploy a specially adapted Ca9 protein for successfully detecting the virus that causes COVID-19.
- The TATA CRSISPER technology has been developed by CSIR-IGIB (Institute of Genomics and Integrative Biology).
- The TATA group had worked closely with ICMR and CSIR-IGIB to create a high-quality test that will be helping the nation ramp up COVID-19 testing quickly and economically, with a ‘Made in India’ test that is reliable, safe, affordable, and accessible.
- The approval for the TATA CRISPER test for the COVID-19 test will be giving a boost to the country’s efforts in fighting the COVID-19 pandemic.
What is TATA CRISPER test and how does it work?
- According to CSIR, the TATA CRISPER test uses an indigenously developed, cutting-edge CRISPER technology for the detection of the genomic sequence of the SARS-CoV-2 virus. CRISPER is a genome editing technology to diagnose diseases.
- According to Anurag Aggarwal, Director, CSIR-IGIB, the work started by the Council of Scientific and Industrial Research (CSIR) under the sickle cell mission for the genome diagnostics and therapeutics led to a new knowledge that can be harnessed to quickly develop the new diagnostic test for SARS-CoV-2.
- Potential of Research & Development in India:
- Girish Krishnamurthy, CEO, TATA Medical and Diagnostic Ltd, while commenting on the development stated that the commercialization of the TATA CRISPER test has been reflecting the tremendous R&D potential in the country which can collaborate for transforming India’s collaboration to the global healthcare and scientific research world.